Marshall Wace, LLP Astrazeneca PLC Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$66.81 - $80.83 $37.3 Million - $45.1 Million
-558,277 Reduced 48.73%
587,360 $45.8 Million
Q1 2024

May 15, 2024
BUY
$61.03 - $69.57 $67.4 Million - $76.9 Million
1,104,864 Added 2709.79%
1,145,637 $77.6 Million
Q4 2023

Feb 14, 2024
BUY
$61.89 - $69.28 $518,143 - $580,012
8,372 Added 25.84%
40,773 $2.75 Million
Q3 2023

Nov 14, 2023
SELL
$64.85 - $71.7 $13 Million - $14.4 Million
-200,513 Reduced 86.09%
32,401 $2.19 Million
Q2 2023

Aug 14, 2023
SELL
$69.91 - $75.81 $15.7 Million - $17 Million
-224,235 Reduced 49.05%
232,914 $16.7 Million
Q1 2023

May 15, 2023
SELL
$63.15 - $71.6 $119 Million - $135 Million
-1,880,091 Reduced 80.44%
457,149 $31.7 Million
Q4 2022

Feb 14, 2023
BUY
$54.21 - $70.44 $28.9 Million - $37.6 Million
533,909 Added 29.61%
2,337,240 $158 Million
Q3 2022

Nov 14, 2022
BUY
$53.02 - $135.75 $16.3 Million - $41.8 Million
307,566 Added 20.56%
1,803,331 $98.9 Million
Q2 2022

Aug 15, 2022
SELL
$59.26 - $71.14 $27 Million - $32.4 Million
-454,954 Reduced 23.32%
1,495,765 $98.8 Million
Q1 2022

May 16, 2022
SELL
$55.72 - $67.12 $4.87 Million - $5.87 Million
-87,399 Reduced 4.29%
1,950,719 $129 Million
Q4 2021

Feb 14, 2022
BUY
$54.02 - $63.83 $99.1 Million - $117 Million
1,834,202 Added 899.49%
2,038,118 $119 Million
Q3 2021

Nov 15, 2021
BUY
$55.56 - $60.79 $6.68 Million - $7.31 Million
120,255 Added 143.74%
203,916 $12.2 Million
Q2 2021

Aug 13, 2021
SELL
$48.42 - $60.18 $5.14 Million - $6.38 Million
-106,084 Reduced 55.91%
83,661 $5.01 Million
Q1 2021

May 17, 2021
BUY
$47.16 - $54.44 $7.47 Million - $8.62 Million
158,301 Added 503.44%
189,745 $9.43 Million
Q4 2020

Feb 16, 2021
BUY
$48.52 - $58.02 $1.53 Million - $1.82 Million
31,444 New
31,444 $1.57 Million
Q3 2020

Nov 16, 2020
SELL
$53.07 - $61.1 $7.71 Million - $8.87 Million
-145,242 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$43.1 - $55.31 $2.96 Million - $3.8 Million
68,786 Added 89.97%
145,242 $7.68 Million
Q1 2020

May 15, 2020
SELL
$37.79 - $51.33 $38.8 Million - $52.7 Million
-1,025,736 Reduced 93.06%
76,456 $3.41 Million
Q4 2019

Feb 14, 2020
SELL
$42.46 - $50.46 $33.3 Million - $39.5 Million
-783,271 Reduced 41.54%
1,102,192 $55 Million
Q3 2019

Nov 14, 2019
SELL
$40.12 - $45.47 $18.5 Million - $20.9 Million
-459,947 Reduced 19.61%
1,885,463 $84 Million
Q2 2019

Aug 14, 2019
BUY
$37.28 - $41.68 $63.3 Million - $70.7 Million
1,697,224 Added 261.84%
2,345,410 $96.8 Million
Q1 2019

May 14, 2019
BUY
$35.49 - $43.02 $23 Million - $27.9 Million
648,186 New
648,186 $26.2 Million
Q3 2018

Nov 14, 2018
SELL
$34.76 - $39.72 $10.4 Million - $11.9 Million
-299,591 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$34.55 - $37.05 $10.4 Million - $11.1 Million
299,591 New
299,591 $10.5 Million

Others Institutions Holding AZN

# of Institutions
1,361
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email